Long-acting risperidone increases medication costs and does not improve outcomes in unstable schizophrenia
- PMID: 23232810
- DOI: 10.1136/eb-2012-101076
Long-acting risperidone increases medication costs and does not improve outcomes in unstable schizophrenia
Comment on
-
Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia.J Clin Psychiatry. 2012 May;73(5):696-702. doi: 10.4088/JCP.11m07070. J Clin Psychiatry. 2012. PMID: 22697193 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources